- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: New FVIII products
Total 3899 results
-
BayerAmerican Thrombosis and Hemostasis NetworkTerminated
-
BayerCompleted
-
CSL BehringCompletedHemophilia AUnited States, Australia, Austria, Canada, Czech Republic, Germany, Hungary, Italy, Japan, Lebanon, Malaysia, Netherlands, Philippines, Poland, Romania, Russian Federation, South Africa, Spain, Ukraine, United Kingdom
-
Skane University HospitalCSL Behring; VersitiCompletedVon Willebrand DiseaseUnited States, Sweden
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumTerminatedHemophilia A | Hemophilia BUnited States
-
Hoffmann-La RocheChugai PharmaceuticalCompletedHemophilia AAustralia, Taiwan, Korea, Republic of, France, Germany, Italy, South Africa, Spain, United States, Japan, Ireland, Poland, United Kingdom, Costa Rica
-
Hospices Civils de LyonTerminated
-
Fondazione Angelo Bianchi BonomiSintesi Research SrlCompletedHemophilia AUnited States, India, Spain, Argentina, Austria, Brazil, Chile, Egypt, Iran, Islamic Republic of, Italy, Mexico, Saudi Arabia, South Africa, Turkey
-
BayerCompleted
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseUnited States, Germany, United Kingdom, Italy, Austria, Canada
-
Chulalongkorn UniversityCompleted
-
Federico II UniversityCompleted
-
Ege UniversityCompletedIncontinence-associated Dermatitis | Nursing CareTurkey
-
CSL BehringCompletedCongenital Hemophilia AUnited States, Austria, Germany, Malaysia, Netherlands, Philippines, Ukraine, Romania, Spain, Australia, France, Georgia, Italy, Lebanon, Poland, Portugal, Switzerland, Thailand, Turkey
-
BayerTerminatedHemophilia ABelgium, Italy, Spain, United States, Canada, Switzerland, Estonia, Taiwan, France, Chile, Netherlands, United Kingdom, Austria, New Zealand, South Africa, Romania, Croatia, Israel, Germany, Poland, Australia, Denmark, Turkey, Argentina, Lithuan... and more
-
Chulalongkorn UniversityCompletedSevere Hemophilia A Without InhibitorThailand
-
AryoGen Pharmed Co.CompletedSevere Hemophilia AIran, Islamic Republic of
-
Baxalta now part of ShireCompletedHemophilia AUnited States, Spain, Netherlands, United Kingdom, Bulgaria, Lithuania, Russian Federation, Switzerland, Ukraine
-
BayerCompletedHemophilia AChina, United States, Ukraine, Taiwan, Mexico, Thailand, Romania, Colombia, Turkey, Serbia, Russian Federation, South Africa, Japan, Indonesia, Argentina, Czech Republic, India, Slovakia
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.; Baxalta Innovations GmbH, now part...Active, not recruitingHemophilia AUnited States, Spain, Hungary, Italy, Germany, Austria, France
-
BayerCompletedHemophilia AUnited States, Japan, United Kingdom, Spain
-
Derming SRLCompletedTelogen Effluvium
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingSeminoma | Germ Cell Tumor | Metachronous Malignant Neoplasm | Stage I Testicular Cancer AJCC v8 | Stage IA Testicular Cancer AJCC v8 | Stage IB Testicular Cancer AJCC v8 | Stage IS Testicular Cancer AJCC v8Canada, United States, Guam
-
Bioverativ Therapeutics Inc.Swedish Orphan BiovitrumCompletedHemophilia AUnited States, Poland, United Kingdom, Netherlands, South Africa, Hong Kong, Australia, Ireland
-
Chulalongkorn UniversityCompleted
-
TakedaNot yet recruitingVon Willebrand Disease (VWD)
-
Coloplast A/SCompletedPeristomal Skin ComplicationNorway
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedAcquired Hemophilia AUnited States, Italy, United Kingdom, Germany, Austria, Netherlands, France
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingVon Willebrand Disease (VWD)United States, Italy, Spain, Netherlands, Turkey, France, Austria, Germany, Russian Federation
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireCompletedAcquired Hemophilia AUnited States
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingVon Willebrand DiseaseUnited States, Belgium, Spain, Italy, Turkey, Germany, Austria, France, Czechia, Russian Federation, Ukraine, United Kingdom, Netherlands
-
BayerCompletedHemophilia A, CongenitalSlovenia, Italy, Germany, France, United States, Belgium, Canada, Colombia, Greece, Luxembourg, Netherlands, Spain, Taiwan
-
Baxalta now part of ShireCompletedVon Willebrand DiseaseNetherlands, Spain, United States, Belgium, Australia, United Kingdom, Austria, Italy, Bulgaria, Japan, Poland, Germany, India, Canada, Russian Federation, Sweden
-
TakedaBaxalta Innovations GmbH, now part of ShireCompletedVon Willebrand DiseaseUnited States, Spain, Italy, Turkey, Germany, Russian Federation, Netherlands, France, Canada
-
Capital Health, CanadaSunnybrook Health Sciences Centre; Erasmus Medical Center; IWK Health Centre; Afexa... and other collaboratorsCompletedRespiratory Tract InfectionCanada, Netherlands
-
Green Cross CorporationAtlantic Research GroupUnknownHemophilia AUnited States, Canada, New Zealand, Poland, Russian Federation, Ukraine, United Kingdom
-
Nutricia ResearchNot yet recruitingPostprandial Glucose Response
-
OctapharmaCompletedVon Willebrand DiseasesLebanon, Croatia, United States, Hungary, Russian Federation, Ukraine, Belarus, Bulgaria
-
OctapharmaCompletedPrevent Bleeding in Major SurgeryUnited States, Turkey, Romania, India, Bulgaria, Italy, Oman, Poland, South Africa
-
PATHCompletedJapanese EncephalitisBangladesh
-
Northwestern UniversityCompleted
-
Peking University First HospitalRecruitingGestational Diabetes | Induction of Labor Affected Fetus / NewbornChina
-
Suranaree University of TechnologyCompletedThe Phenomenon of the Decrease in the Electrical Resistance Within the Conducting Chambers, Making the Increase in a Conducting PropertyThailand
-
Centre hospitalier de l'Université de Montréal...CompletedCOVID-19 InfectionCanada
-
Pepperdine UniversityUniversity of California, Los AngelesCompleted
-
City of Hope Medical CenterCSL Behring; Grifols Therapeutics LLC; Grifols Biologicals, LLC; Charta Foundation and other collaboratorsWithdrawn